http://web.archive.org/web/20130918230606id_/http://www.dailymail.co.uk/news/article-2424409/Human-hair-tablet-Indian-drug-factory-forces-FDA-ban-imports-US.html

by @entity0 published : 10:41 est , 18 september 2013 updated : 16:50 est , 18 september 2013 during a visit to a facility of leading @entity6 drugmaker @entity5 last year , @entity2 inspectors found that a black fiber embedded in a tablet may have been a hair from an employee 's arm , according to documents seen by @entity13			1
that and other quality concerns led the @entity16 to impose an ' import alert ' on its @entity19 plant last week , saying the factory owned by @entity6 's biggest drugmaker by sales had not ensured manufacturing quality			2
@entity5 , which is 63.5 per cent - owned by @entity25 's @entity24 and gets more than 40 per cent of its sales from the @entity2 , did not immediately respond to a request on wednesday for comment on the @entity16 observations			1
@entity5 at @entity31 , on the outskirts of @entity33			0
shares in @entity6 's @entity5 dropped more than 30 per cent this week after the @entity16 issued an import alert @entity5 manufactures a wide range of drugs available in the @entity2 that fight @entity38 's , cholesterol , pain , allergies , and gastrointestinal and cardiovascular issues			1
the @entity16 's action has dealt another blow to an @entity6 generic drug industry battered by a rash of @entity2 regulatory rebukes and as @entity2 demand for generics grows , especially under president @entity52 's new healthcare program			1
the import alert issued to @entity5 prohibits it from making @entity16 - regulated drugs at the @entity19 facility and selling them in the @entity2 until its methods , facilities and controls are in compliance with good manufacturing standards			1
the unexpected import ban on the @entity19 facility sent shares in @entity5 plunging by one - third on monday , and comes just a few months after it pleaded guilty to @entity2 felony charges related to drug safety and agreed to $ 500 million in fines			1
it brings under sanction all three of @entity5 's plants in @entity6 dedicated to supplying the @entity2 , and followed @entity16 inspections in september and december last year			2
during one of the inspections , the @entity16 concluded that a black fiber embedded in a tablet was likely either ' tape remnants on the nozzle head of the machine or a hair from an employee 's arm that could be exposed on loading the machine ' , the documents showed			0
president @entity52 speaks at the @entity86 as he faces another budget showdown with @entity88			0
the @entity89 has seen an increase in demand for cheap generic drugs , many of which are manufactured in @entity6 according to the @entity16 , the ban means that @entity2 officials may detain drugs manufactured at @entity5 facility in @entity19 , @entity6			1
' the @entity16 is committed to using the full extent of its enforcement authority to ensure that drugs made for the @entity2 market meet federally mandated quality standards , ' said @entity104 , director of the @entity105 in the @entity16 â€™s @entity106 in a statement			2
' we want @entity2 consumers to be confident that the drugs they are taking are of the highest quality			2
' @entity5 had said on tuesday it would review the details of the @entity16 import alert and take ' all necessary steps to resolve the concerns ' at the earliest			0
' the @entity16 had conducted inspections at @entity5 's @entity19 facility in 2012 , resulting in certain observations , ' @entity5 said in the statement			0
' the company believes that it has made further improvements at its @entity19 facility ... and remains committed to addressing all concerns of the @entity16			0
' the @entity19 plant , in the northern state of @entity126 , had not been making @entity2 exports since last november , when it voluntarily recalled its generic version of cholesterol - lowering drug @entity129 in the @entity2 due to the potential presence of glass particles in certain batches			1
the @entity16 's ban of @entity2 shipments from the @entity19 plant was unexpected as the facility is relatively new and accounted for 50 per cent of new generic drug filings by @entity5 , said @entity139 , a sector analyst at @entity140			1
the latest action against @entity5 came months after the @entity16 imposed an import ban on one of the plants of @entity145 after inspectors found torn data records in a waste heap and urinals that emptied into an open drain in a bathroom six meters from the entrance to a sterile manufacturing area			2
@entity145 chairman @entity154 said this month the problem at its @entity157 plant was ' an inexcusable lapse , but we have taken swift and definitive action , both corrective and pre-emptive '			0
the @entity2 government has banned imports of drugs manufactured by a company in @entity6			1
this stock photo is not related to @entity5 or any currently manufactured drug @entity6 produces nearly 40 per cent of generic drugs and over-the - counter products and 10 perc ent of finished dosages used in the @entity2			1
in march , @entity6 allowed the @entity16 to add seven inspectors , which will bring its staff in @entity6 to 19			0
in @entity5 's case , the @entity16 inspections in @entity19 also found that a tablet was not within the specified weight limit , the @entity16 inspectors wrote			0
other findings by the @entity16 included use of dirty glassware , spots and abrasions on the surface of tablets and potential packaging line failure that resulted in unlabeled bottles sent to pharmacies			0
the latest @entity5 import ban and a weak rupee may force @entity24 to revise down full - year guidance when it announces first half earnings on october 31 , @entity189 , an analyst with @entity190 wrote in a report			0
' it appears @entity5 still has problems that need to be resolved , ' @entity189 wrote			0
@entity5 has lost half its value from its highest level in 2008 , when it was first hit by an import ban			0
@entity5 's chief executive @entity200 is under pressure after inspectors from the @entity2 government 's @entity16 discovered suspected ' human hair ' in a pill manufactured by the company			2
@entity5 is a major exporter of generic drugs to the @entity2			1

@entity210 recently plead guilty to felony charges over drug safety
@entity89 spikes demand for generic drugs from @entity6
shares crash for company after latest manufacturing setback
@entity6 produces 40 per cent of generic drugs and over-the - counter products and 10 per cent of finished dosages used in @entity2

@entity24:Daiichi Sankyo
@entity25:Japan
@entity139:Sarabjit Kour Nangra
@entity86:White House
@entity88:Congress
@entity89:Obamacare
@entity157:Waluj
@entity154:Habil Khorakiwala
@entity2:US
@entity0:Reuters Reporter
@entity210:Ranbaxy Labs
@entity6:India
@entity5:Ranbaxy Laboratories
@entity190:Barclays Japan
@entity52:Barack Obama
@entity31:Gurgaon
@entity16:Food and Drug Administration
@entity33:New Delhi
@entity13:Reuters
@entity145:Wockhardt
@entity38:Alzheimer
@entity19:Mohali
@entity104:Howard Sklamberg
@entity105:Office of Compliance
@entity106:Center for Drug Evaluation and Research
@entity129:Lipitor
@entity126:Punjab
@entity200:Arun Sawhney
@entity189:Seki
@entity140:Angel Broking